Citation Impact
Citing Papers
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Physical traits of cancer
2020 Science
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis
2014
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis
2019
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
2013
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis
2014
Resection of Hepatocellular Carcinoma Without Cirrhosis
2012
Absence of Viable HCC in the Native Liver Is an Independent Protective Factor of Tumor Recurrence After Liver Transplantation
2013
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
2011
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Hepatocellular carcinoma
2003 Standout
A bridge too far: We have not overstepped the line for extended deceased donors
2014
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatitis C and liver transplantation
2005 Nature
Right Hepatectomy for Living Liver Donation vs Right Hepatectomy for Disease
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis
2016
Pancreatic cancer
2020 Standout
Neutrophil‐to‐lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation
2011
The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery
2016
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
2014
Comparison of Seven Staging Systems in Cirrhotic Patients With Hepatocellular Carcinoma in a Cohort of Patients Who Underwent Radiofrequency Ablation With Complete Response
2007
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model”
2015
Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort
2012
Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis
2009
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
2016
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
2018
Extracapsular Penetration is a New Prognostic Factor in Human Hepatocellular Carcinoma
2008
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
Surgical Treatment of Neuroendocrine Metastases to the Liver
2003
Classification of Surgical Complications
2004 Standout
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2012 Standout
Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria
2013
Prognosis prediction and staging
2014
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
2017
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
2016
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
2013
Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion
2016
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study
2002
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Endocannabinoids in liver disease
2010
Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: A single-center experience
2008
Validation of the HCC‐MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
2008
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver Stiffness Measurement by Transient Elastography as a Predictor on Posthepatectomy Outcomes
2012
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
2009
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
2010
Liver Transplantation for Hepatocellular Carcinoma
2008
Liver Transplantation With Older Donors
2016
Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
2012
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
2017
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Non-alcoholic fatty liver disease
2021 Standout
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Liver cancer: Approaching a personalized care
2015
Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?
2011
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
2002
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation
2010
Increased morbidity in overweight and obese liver transplant recipients
2013
Treating hepatitis C
2005 StandoutNobel
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation
2017
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
2015
Chronic hepatitis B
2007 Standout
Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver
2008
Liver transplantation and hepatitis C
2011
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
2014
Systemic amyloidosis
2015 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience
2015
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers
2013
Personalized treatment of patients with very early hepatocellular carcinoma
2016
Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma
2015
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Loco‐regional treatment of hepatocellular carcinoma†
2010
The place of downstaging for hepatocellular carcinoma
2010
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors
2011
Differences in Surgical Outcomes Between Hepatitis B- and Hepatitis C–Related Hepatocellular Carcinoma
2014
Recurrence After Liver Transplantation for Hepatocellular Carcinoma
2016
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
2011
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Quality of Complication Reporting in the Surgical Literature
2002
Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
2012
Hepatocellular Carcinoma
2011
Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?
2016
Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
2012
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Surgical approach for hepatitis C virus-related hepatocellular carcinoma
2015
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list
2012
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America
2016
NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice
2014
Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy
2007
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
2006
Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results
2007
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
2016
Hepatocellular Carcinoma
2011 Standout
Actual 10-year survival following hepatectomy for hepatocellular carcinoma
2013
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Treatment of Hepatocellular Carcinoma
2016
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies
2012
Historical perspective of living donor liver transplantation
2008
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Second hepatic resection for recurrent hepatocellular cancer: A Western experience
2010
Biliary complications in right lateral sector graft live donor liver transplantation
2008
Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation?
2008
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
2011
Living donor liver transplantation for hepatocellular carcinoma in Seoul National University
2016
Hepatocellular carcinoma
2022 Standout
The model for end-stage liver disease (MELD)
2007
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
2013
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
2008
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
Complications of radiofrequency coagulation of liver tumours
2002
Assessment of Hepatic Function, Operative Candidacy, and Medical Management after Liver Resection in the Patient with Underlying Liver Disease
2013
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
2015
Hepatocellular Carcinoma
2019 Standout
Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
2013
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria
2015
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
2015
Excellent post‐transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy
2015
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
2009
Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1)
2018
Preoperative Neutrophil‐to‐Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
2008
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation
2014
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
2013
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation
2016
Does the preoperative alpha‐fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?
2014
Is it Time to Abandon the Milan Criteria?
2018
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
2014
The role of hepatic resection in the treatment of hepatocellular cancer
2015
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End‐Stage Liver Disease Score
2009
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention‐to‐treat analysis
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma
2013
Prospective validation of the Barcelona Clinic Liver Cancer staging system
2006
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
2012
Comparison of hepatocellular carcinoma in E astern versus W estern populations
2016
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Safe Hepatectomy Selection Criteria for Hepatocellular Carcinoma Patients: A Validation of 336 Consecutive Hepatectomies. The BILCHE Score
2014
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
2013
Tumor biology and pre‐transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
2013
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis
2017
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy
2013
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey
2017
Management of hepatocellular carcinoma: an overview of major findings from meta-analyses
2016
Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria
2014
Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection
2015
Works of Matteo Cescon being referenced
Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience
2008
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population
2012
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
2013
Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables
2009
Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population
2008
Improved Diagnostic Imaging and Interventional Therapies Prolong Survival After Resection for Hepatocellular Carcinoma in Cirrhosis: The University of Bologna Experience Over 10 Years
2010
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria
2008
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma
2020
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation
2006
A Revised Consideration on the Use of Very Aged Donors for Liver Transplantation
2001
Role of Hepatitis B Virus Infection in the Prognosis After Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis
2009
Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy
2011
Cost-effectiveness of liver cancer screening
2013
The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery☆☆☆
2000
Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma
2013
Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: results from a retrospective multicentric study
2015
Liver Allocation for Hepatocellular Carcinoma: A European Center Policy in the Pre-MELD Era
2006
Liver Transplantation with the Meld System: A Prospective Study from a Single European Center
2006
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis
2009
Partial Necrosis on Hepatocellular Carcinoma Nodules Facilitates Tumor Recurrence after Liver Transplantation
2004
Trends in Perioperative Outcome After Hepatic Resection
2009
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit
2014
A Comprehensive Meta-regression Analysis on Outcome of Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma
2012
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
2010
Survival Benefit After Liver Transplantation: A Single European Center Experience
2009
Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
2008
Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria
2004
Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients
2010
The chances of hepatic resection curing hepatocellular carcinoma
2019
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
2015
Long-term survival of recipients of liver grafts from donors older than 80 years: Is it achievable?
2003
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients
2005
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center
2004
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
2006
The Role of Liver Resections for Noncolorectal, Nonneuroendocrine Metastases: Experience With 142 Observed Cases
2005
Absence of Neuroinvasive Disease in a Liver Transplant Recipient Who Acquired West Nile Virus (WNV) Infection from the Organ Donor and Who Received WNV Antibodies Prophylactically
2010
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate
2012
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
2018
Liver Resection for Hepatocellular Carcinoma on Cirrhosis
2003
Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added Value
2001
Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score
2014
Is Portal Hypertension a Contraindication to Hepatic Resection?
2009
Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long‐term survival and tumour recurrence in a single centre
2003
Impact of biliary complications in right lobe living donor liver transplantation
2006
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma
2012
Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?
2011
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
2020
Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?
2009
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
2015
Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis
2013
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
2017
Right liver graft without middle hepatic vein reconstruction from a living donor1
2002
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation
2011
Recovery from Liver Failure after Hepatectomy for Hepatocellular Carcinoma in Cirrhosis: Meaning of the Model for End-Stage Liver Disease
2006
An appraisal of percutaneous treatment of liver metastases
1998
The Role of Lymphadenectomy for Liver Tumors
2004
Harm and Benefits of Primary Liver Resection and Salvage Transplantation for Hepatocellular Carcinoma
2010
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
2013
Feasibility and Limits of Split Liver Transplantation From Pediatric Donors
2006
Intrahepatic Cholangiocarcinoma
2010
When to perform hepatic resection for intermediate‐stage hepatocellular carcinoma
2014
Effect of age on survival in patients undergoing resection of hepatocellular carcinoma
2015
Outcome of Right Hepatectomies in Patients Older Than 70 Years
2003
Liver Resection for Hepatocellular Carcinoma on Cirrhosis: Univariate and Multivariate Analysis of Risk Factors for Intrahepatic Recurrence
2003
Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
2000
Predictors of Sustained Virological Response After Antiviral Treatment for Hepatitis C Recurrence Following Liver Transplantation
2009
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
2004
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy?
2009
Does Surgical Resection Have a Role in the Treatment of Large or Multinodular Hepatocellular Carcinoma?
2010
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
2018
Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma
2010
Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers
2011
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature
2018